Switzerland· 62363002
Optava Unit Dose, Augentropfen
A künstliche tränenflüssigkeit und sonstige indifferente präparate product containing carmellosum natricum, registered in Switzerland by AbbVie AG and dispensed under Swissmedic category D, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Künstliche tränenflüssigkeit und sonstige indifferente präparate is registered in 11 of 19 countries.
Countries holding a registration under ATC S01XA20 (künstliche tränenflüssigkeit und sonstige indifferente präparate), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Künstliche tränenflüssigkeit und sonstige indifferente präparate · ATC S01XA20
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- carmellosum natricum
- Manufacturer
- AbbVie AG
- Country
- Switzerland (CH)
- ATC code
- S01XA20
- ATC class
- Künstliche Tränenflüssigkeit und sonstige indifferente Präparate
- Swissmedic category
- D
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768062363002530 x 0.4 mlCHF 16.95
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Künstliche tränenflüssigkeit und sonstige indifferente präparate in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCELLUFLUIDAbbVie s.r.o., Praha
- NetherlandsCellufluid 0,5%, oogdruppels, oplossing, unit dose ampul, 5 mg/mlAbbVie B.V.
- United KingdomAaqEye Carmellose 0.5% eye dropsEssential-Healthcare Ltd
- SpainACUVISC 5 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSISTiedra Farmaceutica S.L.
- United StatesDRMITSUI HYDROCOLLOID WOUNDYIYANGYUAN LIFE SCIENCES (HONG KONG) CO., LIMITED
- IrelandCelluvisc 0.5 % w/v eye drops solution, unit doseAbbVie Limited
- FranceCELLUVISC 4 mg/0,4 ml, collyre en récipient unidoseABBVIE
- GermanyCelluviscAbbvie Deutschland Gmbh & Co. Kg
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Czechia · Cellufluid
- Denmark · Celluvisc
- Spain · Carmelosa Qualigen, Carmelosa Stada
- Finland · Celluvisc
- France · Celluvisc
- United Kingdom (Northern Ireland) · Celluvisc
- Greece · Refresh Plus
- Ireland · Celluvisc
- Italy · Celluvisc
- Netherlands · Cellufluid, Celluvisc
- Portugal · Celluvisc
- Sweden · Cellufluid, Celluvisc
- Slovakia · Cellufluid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/48b561e7-1bbd-4d77-a766-902c13beb8e1 GET /v1/drugs/48b561e7-1bbd-4d77-a766-902c13beb8e1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "carmellosum natricum 5 mg",
"valid_from": "2014-01-01",
"limitations": null,
"galenic_form": "Gtt Opht 5 mg/ml",
"therapeutic_area": null,
"sl_inclusion_date": "2014-01-01",
"self_retention_pct": 10
}See everything about künstliche tränenflüssigkeit und sonstige indifferente präparate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.